Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Torques within and outside the human spindle balance twist at anaphase.
Neahring L, He Y, Cho NH, Liu G, Fernandes J, Rux CJ, Nakos K, Subramanian R, Upadhyayula S, Yildiz A, Dumont S. Neahring L, et al. Among authors: subramanian r. bioRxiv [Preprint]. 2023 Dec 10:2023.12.10.570990. doi: 10.1101/2023.12.10.570990. bioRxiv. 2023. Update in: J Cell Biol. 2024 Sep 2;223(9):e202312046. doi: 10.1083/jcb.202312046. PMID: 38405786 Free PMC article. Updated. Preprint.
Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
Nirogi R, Shinde A, Goyal VK, Ravula J, Benade V, Jetta S, Pandey SK, Subramanian R, Chowdary Palacharla VR, Mohammed AR, Abraham R, Dogiparti DK, Kalaikadhiban I, Jayarajan P, Jasti V, Bogan RK. Nirogi R, et al. Among authors: subramanian r. Sleep Med. 2024 Oct 30;124:618-626. doi: 10.1016/j.sleep.2024.10.037. Online ahead of print. Sleep Med. 2024. PMID: 39504585
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
Ahn DH, Ridinger M, Cannon TL, Mendelsohn L, Starr JS, Hubbard JM, Kasi A, Barzi A, Samuëlsz E, Karki A, Subramanian RA, Yemane D, Kim R, Wu CC, Croucher PJP, Smeal T, Kabbinavar FF, Lenz HJ. Ahn DH, et al. Among authors: subramanian ra. J Clin Oncol. 2024 Oct 30:JCO2401266. doi: 10.1200/JCO-24-01266. Online ahead of print. J Clin Oncol. 2024. PMID: 39475591
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.
Durno N, Arija P, Pantiri K, Heisen M, Boeri M, Paris J, Jack K, Chambenoit O, Subramanian R, Puelles J, Stolk E, van Hout B, Silverberg JI. Durno N, et al. Among authors: subramanian r. J Dermatolog Treat. 2024 Dec;35(1):2417966. doi: 10.1080/09546634.2024.2417966. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462516 Free article.
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.
Wang W, Bhushan G, Paz S, Stauft CB, Selvaraj P, Goguet E, Bishop-Lilly KA, Subramanian R, Vassell R, Lusvarghi S, Cong Y, Agan B, Richard SA, Epsi NJ, Fries A, Fung CK, Conte MA, Holbrook MR, Wang TT, Burgess TH, Pollett SD, Mitre E, Katzelnick LC, Weiss CD. Wang W, et al. Among authors: subramanian r. J Virol. 2024 Oct 4:e0094824. doi: 10.1128/jvi.00948-24. Online ahead of print. J Virol. 2024. PMID: 39365051
752 results